Design Therapeutics, Inc. (DSGN)
11.65
+0.16
(+1.39%)
USD |
NASDAQ |
Oct 09, 16:00
11.65
0.00 (0.00%)
After-Hours: 20:00
Design Therapeutics Market Cap : 729.06M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 729.06M |
| October 08, 2026 | 719.05M |
| October 07, 2026 | 731.56M |
| October 06, 2026 | 749.08M |
| October 05, 2026 | 777.24M |
| October 02, 2026 | 772.24M |
| October 01, 2026 | 765.98M |
| September 30, 2026 | 786.63M |
| September 29, 2026 | 789.76M |
| September 28, 2026 | 773.49M |
| September 25, 2026 | 758.47M |
| September 24, 2026 | 765.98M |
| September 23, 2026 | 773.49M |
| September 22, 2026 | 823.55M |
| September 21, 2026 | 785.38M |
| September 18, 2026 | 765.98M |
| September 17, 2026 | 801.65M |
| September 16, 2026 | 782.56M |
| September 15, 2026 | 765.04M |
| September 14, 2026 | 846.08M |
| September 11, 2026 | 915.55M |
| September 10, 2026 | 926.19M |
| September 09, 2026 | 939.95M |
| September 08, 2026 | 953.09M |
| September 04, 2026 | 947.46M |
| Date | Value |
|---|---|
| September 03, 2026 | 940.58M |
| September 02, 2026 | 971.87M |
| September 01, 2026 | 947.46M |
| August 31, 2026 | 944.33M |
| August 28, 2026 | 945.59M |
| August 27, 2026 | 954.35M |
| August 26, 2026 | 975.62M |
| August 25, 2026 | 981.26M |
| August 24, 2026 | 953.09M |
| August 21, 2026 | 938.08M |
| August 20, 2026 | 973.75M |
| August 19, 2026 | 997.53M |
| August 18, 2026 | 955.60M |
| August 17, 2026 | 944.96M |
| August 14, 2026 | 928.06M |
| August 13, 2026 | 900.53M |
| August 12, 2026 | 917.42M |
| August 11, 2026 | 914.92M |
| August 10, 2026 | 896.77M |
| August 07, 2026 | 875.50M |
| August 06, 2026 | 861.73M |
| August 05, 2026 | 849.21M |
| August 04, 2026 | 826.06M |
| August 03, 2026 | 798.52M |
| July 31, 2026 | 762.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Palvella Therapeutics, Inc. | 1.998B |
| Agenus, Inc. | 326.86M |
| Amgen, Inc. | 224.28B |
| Anika Therapeutics, Inc. | 262.04M |
| BioCryst Pharmaceuticals, Inc. | 2.183B |
Market Cap Related Metrics
| PEG Ratio | -1.790 |
| Price to Book Value | 3.612 |
| Price | 11.65 |
| Earnings Yield | -10.13% |
| PEGY Ratio | -1.790 |